YS VS PRE Stock Comparison

PerformanceVolatilityTechnicalsEarningsProfit
PerformanceVolatilityTechnicalsEarningsProfit

Performance

YS
10/100

YS returned -94.73% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

PRE
10/100

PRE returned -86.81% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Volatility

YS
23/100

YS has had a lower than average amount of volatility over the last 12 months giving it a score of 22 of 100.

PRE
55/100

PRE has had a higher than average amount of volatility over the last 12 months giving it a score of 54 of 100.

Technicals

YS

"Technicals" not found for YS

PRE
36/100

PRE receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.

Earnings

YS

"Earnings" not found for YS

PRE
44/100

PRE has missed earnings 2 times in the last 20 quarters.

Profit

YS

"Profit" not found for YS

PRE
13/100

Out of the last 10 quarters, PRE has had 2 profitable quarters and has increased their profits year over year on 1 of them.

All score calculations are broken down here to help you make more informed investing decisions

YS Biopharma Co., Ltd. Ordinary Shares Summary

Nasdaq / YS
Healthcare
Biotechnology
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Prenetics Global Limited Class A Ordinary Share Summary

Nasdaq / PRE
Healthcare
Medical - Diagnostics & Research
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.